kf 17837s has been researched along with enprofylline in 1 studies
| Studies (kf 17837s) | Trials (kf 17837s) | Recent Studies (post-2010) (kf 17837s) | Studies (enprofylline) | Trials (enprofylline) | Recent Studies (post-2010) (enprofylline) |
|---|---|---|---|---|---|
| 39 | 0 | 0 | 220 | 41 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, Y; Morishima, T; Tsuge, M; Wada, T; Yashiro, M; Yasui, K | 1 |
1 other study(ies) available for kf 17837s and enprofylline
| Article | Year |
|---|---|
Theophylline inhibits the differentiation of human monocyte into dendritic cell potentially via adenosine receptor antagonism.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); Adult; Apoptosis; Caspase 3; CD11c Antigen; Cell Differentiation; Dendritic Cells; Granulocyte-Macrophage Colony-Stimulating Factor; HLA-DR Antigens; Humans; Interleukin-4; Male; Monocytes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptors, Purinergic P1; Recombinant Proteins; RNA, Small Interfering; Rolipram; Theophylline; Xanthines | 2009 |